| Product Code: ETC7744147 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Oncology Molecular Diagnostic Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 Japan Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 Japan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Japan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.8 Japan Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Japan Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Japan |
4.2.2 Rising demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in molecular diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for molecular diagnostics |
4.3.2 High cost associated with molecular diagnostic tests |
4.3.3 Limited reimbursement policies for molecular diagnostic procedures |
5 Japan Oncology Molecular Diagnostic Market Trends |
6 Japan Oncology Molecular Diagnostic Market, By Types |
6.1 Japan Oncology Molecular Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Oncology Molecular Diagnostic Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2.4 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Oncology Molecular Diagnostic Market, By Test Location |
6.3.1 Overview and Analysis |
6.3.2 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F |
6.3.4 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.4 Japan Oncology Molecular Diagnostic Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F |
6.4.4 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.5 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.4.6 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F |
6.4.7 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F |
6.4.8 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Oncology Molecular Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Japan Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 Japan Oncology Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 Japan Oncology Molecular Diagnostic Market Export to Major Countries |
7.2 Japan Oncology Molecular Diagnostic Market Imports from Major Countries |
8 Japan Oncology Molecular Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostic tests in oncology practice |
8.2 Number of research and development collaborations for new molecular diagnostic technologies |
8.3 Percentage of oncology patients receiving molecular diagnostic testing before treatment decisions |
9 Japan Oncology Molecular Diagnostic Market - Opportunity Assessment |
9.1 Japan Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Japan Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
9.4 Japan Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Japan Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Oncology Molecular Diagnostic Market - Competitive Landscape |
10.1 Japan Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Japan Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here